473 related articles for article (PubMed ID: 32556463)
1. Reduction of respiratory motion artifacts in gadoxetate-enhanced MR with a deep learning-based filter using convolutional neural network.
Kromrey ML; Tamada D; Johno H; Funayama S; Nagata N; Ichikawa S; Kühn JP; Onishi H; Motosugi U
Eur Radiol; 2020 Nov; 30(11):5923-5932. PubMed ID: 32556463
[TBL] [Abstract][Full Text] [Related]
2. Gadoxetate disodium-related event during image acquisition: a prospective multi-institutional study for better MR practice.
Kromrey ML; Hori M; Goshima S; Kozaka K; Hyodo T; Nakamura Y; Nishie A; Tamada T; Shimizu T; Kanki A; Motosugi U
Eur Radiol; 2020 Jan; 30(1):281-290. PubMed ID: 31338655
[TBL] [Abstract][Full Text] [Related]
3. Transient respiratory motion artifacts in multiple arterial phases on abdominal dynamic magnetic resonance imaging: a comparison using gadoxetate disodium and gadobutrol.
Tanabe M; Higashi M; Iida E; Onoda H; Ihara K; Ariyoshi S; Kameda F; Miyoshi K; Furukawa M; Okada M; Ito K
Jpn J Radiol; 2021 Feb; 39(2):178-185. PubMed ID: 32959222
[TBL] [Abstract][Full Text] [Related]
4. Matched within-patient cohort study of transient arterial phase respiratory motion-related artifact in MR imaging of the liver: gadoxetate disodium versus gadobenate dimeglumine.
Davenport MS; Caoili EM; Kaza RK; Hussain HK
Radiology; 2014 Jul; 272(1):123-31. PubMed ID: 24617733
[TBL] [Abstract][Full Text] [Related]
5. CAIPIRINHA-Dixon-TWIST (CDT)-VIBE MR imaging of the liver at 3.0T with gadoxetate disodium: a solution for transient arterial-phase respiratory motion-related artifacts?
Gruber L; Rainer V; Plaikner M; Kremser C; Jaschke W; Henninger B
Eur Radiol; 2018 May; 28(5):2013-2021. PubMed ID: 29264636
[TBL] [Abstract][Full Text] [Related]
6. Compressed Sensing and Parallel Imaging for Double Hepatic Arterial Phase Acquisition in Gadoxetate-Enhanced Dynamic Liver Magnetic Resonance Imaging.
Yoon JK; Kim MJ; Lee S
Invest Radiol; 2019 Jun; 54(6):374-382. PubMed ID: 30724814
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of incidence of acute transient dyspnea and related artifacts after administration of gadoxetate disodium: a prospective observational study.
Grazioli L; Faletti R; Frittoli B; Battisti G; Ambrosini R; Romanini L; Gatti M; Fonio P
Radiol Med; 2018 Dec; 123(12):910-917. PubMed ID: 30084108
[TBL] [Abstract][Full Text] [Related]
8. Transient Severe Motion Artifact Related to Gadoxetate Disodium-Enhanced Liver MRI: Frequency and Risk Evaluation at a German Institution.
Well L; Rausch VH; Adam G; Henes FO; Bannas P
Rofo; 2017 Jul; 189(7):651-660. PubMed ID: 28445909
[No Abstract] [Full Text] [Related]
9. Comparison of transient severe motion in gadoxetate disodium and gadopentetate dimeglumine-enhanced MRI: effect of modified breath-holding method.
Song JS; Choi EJ; Park EH; Lee JH
Eur Radiol; 2018 Mar; 28(3):1132-1139. PubMed ID: 28986630
[TBL] [Abstract][Full Text] [Related]
10. Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: examination recovery with a multiple arterial phase acquisition.
Pietryga JA; Burke LM; Marin D; Jaffe TA; Bashir MR
Radiology; 2014 May; 271(2):426-34. PubMed ID: 24475864
[TBL] [Abstract][Full Text] [Related]
11. Motion Artifact Reduction Using a Convolutional Neural Network for Dynamic Contrast Enhanced MR Imaging of the Liver.
Tamada D; Kromrey ML; Ichikawa S; Onishi H; Motosugi U
Magn Reson Med Sci; 2020 Feb; 19(1):64-76. PubMed ID: 31061259
[TBL] [Abstract][Full Text] [Related]
12. Second shot arterial phase to overcome degraded hepatic arterial phase in liver MR imaging.
Park YS; Lee J; Kim JW; Park CM; Lee CH
Eur Radiol; 2019 Jun; 29(6):2821-2829. PubMed ID: 30552478
[TBL] [Abstract][Full Text] [Related]
13. Gadoxetate acid disodium-enhanced MRI: Multiple arterial phases using differential sub-sampling with cartesian ordering (DISCO) may achieve more optimal late arterial phases than the single arterial phase imaging.
Wei Y; Deng L; Yuan Y; Huang Z; He X; Wei X; Yang H; Song B
Magn Reson Imaging; 2019 Sep; 61():116-123. PubMed ID: 31129279
[TBL] [Abstract][Full Text] [Related]
14. Transient respiratory motion artifact during arterial phase MRI with gadoxetate disodium: risk factor analyses.
Kim SY; Park SH; Wu EH; Wang ZJ; Hope TA; Chang WC; Yeh BM
AJR Am J Roentgenol; 2015 Jun; 204(6):1220-7. PubMed ID: 26001231
[TBL] [Abstract][Full Text] [Related]
15. Respiratory motion artefacts in dynamic liver MRI: a comparison using gadoxetate disodium and gadobutrol.
Luetkens JA; Kupczyk PA; Doerner J; Fimmers R; Willinek WA; Schild HH; Kukuk GM
Eur Radiol; 2015 Nov; 25(11):3207-13. PubMed ID: 25903709
[TBL] [Abstract][Full Text] [Related]
16. Reduction in respiratory motion artefacts on gadoxetate-enhanced MRI after training technicians to apply a simple and more patient-adapted breathing command.
Gutzeit A; Matoori S; Froehlich JM; von Weymarn C; Reischauer C; Kolokythas O; Goyen M; Hergan K; Meissnitzer M; Forstner R; Soyka JD; Doert A; Koh DM
Eur Radiol; 2016 Aug; 26(8):2714-22. PubMed ID: 26573682
[TBL] [Abstract][Full Text] [Related]
17. Biologic factors affecting HCC conspicuity in hepatobiliary phase imaging with liver-specific contrast agents.
Kim JY; Lee SS; Byun JH; Kim SY; Park SH; Shin YM; Lee MG
AJR Am J Roentgenol; 2013 Aug; 201(2):322-31. PubMed ID: 23883212
[TBL] [Abstract][Full Text] [Related]
18. Respiratory motion artifact affecting hepatic arterial phase MR imaging with gadoxetate disodium is more common in patients with a prior episode of arterial phase motion associated with gadoxetate disodium.
Bashir MR; Castelli P; Davenport MS; Larson D; Marin D; Hussain HK; Jaffe TA
Radiology; 2015 Jan; 274(1):141-8. PubMed ID: 25162310
[TBL] [Abstract][Full Text] [Related]
19. Intravenous Gadoxetate Disodium Administration Reduces Breath-holding Capacity in the Hepatic Arterial Phase: A Multi-Center Randomized Placebo-controlled Trial.
McClellan TR; Motosugi U; Middleton MS; Allen BC; Jaffe TA; Miller CM; Reeder SB; Sirlin CB; Bashir MR
Radiology; 2017 Feb; 282(2):361-368. PubMed ID: 27509544
[TBL] [Abstract][Full Text] [Related]
20. Transient Severe Respiratory Motion Artifacts After Application of Gadoxetate Disodium: What We Currently Know.
Well L; Weinrich JM; Adam G; Bannas P
Rofo; 2018 Jan; 190(1):20-30. PubMed ID: 29156475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
